SCHEMBL7965285

SCHEMBL7965285

Nc1nc(-c2ccccc2OCc2ccccc2)[nH]c(=O)c1N=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.57
MEN1 O00255 1/20 0.57
MAPT P10636 1/20 0.57
CASP6 P55212 1/20 0.57
KMT2A Q03164 1/20 0.57
MGMT P16455 3/20 0.52
CDK1 P06493 3/20 0.52
CDK2 P24941 3/20 0.52
CCNB1 P14635 1/20 0.52
CCNA2 P20248 1/20 0.52
CCNA1 P78396 1/20 0.52
PDE5A O76074 4/20 0.50
PDE4A P27815 1/20 0.50
PDE4B Q07343 1/20 0.50
PDE4C Q08493 1/20 0.50
PDE4D Q08499 1/20 0.50
GUSB P08236 1/20 0.46
LTA4H P09960 1/20 0.43
MAPK14 Q16539 1/20 0.43
BRD4 O60885 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7962891 0.84 PDE5A (0.57) KDM4EMEN1MAPTCASP6KMT2A
SCHEMBL7958810 0.83 KDM4E (0.53) KDM4EMEN1MAPTCASP6KMT2A
SCHEMBL11628099 0.74 PDE5A (0.46) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL4142417 0.74 HTT (0.50) MEN1KMT2APDE5APDE4APDE4B
SCHEMBL11629646 0.73 IDO1 (0.47) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL7950714 0.71 PDE5A (0.52) KDM4EMEN1MAPTCASP6KMT2A
SCHEMBL29362917 0.70 KDM4E (0.46) KDM4EMEN1MAPTCASP6KMT2A
SCHEMBL22264907 0.70 KDM4E (0.46) KDM4EMEN1MAPTCASP6KMT2A
SCHEMBL7950444 0.70 KDM4E (0.45) KDM4EMEN1MAPTCASP6KMT2A
SCHEMBL30835050 0.70 PDE5A (0.70) KDM4EMAPTCDK1CDK2PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6200980-B1 ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS CELL PATHWAYS, INC. 2001-03-13 US disclosed
EP-0352960-B1 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE FRENCH LAB (GB) 1994-10-26 EP disclosed
US-5073559-A 2-Substituted purinone having phosphodiesterase inhibitory activity SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1991-12-17 US disclosed
EP-0352960-A2 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-01-31 EP disclosed